- Trials with a EudraCT protocol (31)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
31 result(s) found for: Instrumentation.
Displaying page 1 of 2.
EudraCT Number: 2014-002644-40 | Sponsor Protocol Number: B3451002 | Start Date*: 2015-05-27 | ||||||||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017 | ||||||||||||||||||
Full Title: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Staphylococcus Aureus 4-Antigen Vaccine (SA4Ag) in Adults Undergoing Elective Posterior Instrum... | ||||||||||||||||||
Medical condition: Prophylaxis for prevention of Post-operative S. aureus infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) GB (Prematurely Ended) DE (Prematurely Ended) HU (Completed) AT (Prematurely Ended) SE (Prematurely Ended) BG (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000470-19 | Sponsor Protocol Number: CHUB-PD001 | Start Date*: 2014-04-17 |
Sponsor Name:Centre Hospitalier Universitaire Brugmann | ||
Full Title: comparative study between conventional epidural versus ambulatory epidural: effect during labor in pregnant women | ||
Medical condition: a single fetus pregnancy over 36 weeks and less than 42 weeks in adult nulliparous | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002887-14 | Sponsor Protocol Number: 2.0 | Start Date*: 2016-10-31 | |||||||||||
Sponsor Name:University of Turku | |||||||||||||
Full Title: Dose response study of Patient Controlled Analgesia (PCA) of S-ketamine in orthopaedic spine surgery patients | |||||||||||||
Medical condition: Patients who are scheduled for elective posterolateral lumbar spine fusion with bilateral transpedicular screw instrumentation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003252-31 | Sponsor Protocol Number: 2.0 | Start Date*: 2015-05-15 | |||||||||||
Sponsor Name:University of Turku | |||||||||||||
Full Title: Dose response study of Patient Controlled Analgesia (PCA) of Dexmedetomidine in orthopaedic spine surgery patients | |||||||||||||
Medical condition: Patients, who are scheduled for elective posterolateral lumbar spine fusion with bilateral transpedicular screw instrumentation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003999-38 | Sponsor Protocol Number: Bay a 0128/11799 | Start Date*: 2006-04-06 | |||||||||||
Sponsor Name:Bayer Pharmaceuticals Corporation | |||||||||||||
Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal ... | |||||||||||||
Medical condition: Elective Spinal Fusion Surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002416-16 | Sponsor Protocol Number: ALLOB-RIF1 | Start Date*: 2014-08-04 | |||||||||||
Sponsor Name:Bone Therapeutics S.A. | |||||||||||||
Full Title: A Pilot Phase IIa, Multicentre, Open, Proof-of-concept Study on the Safety and the Efficacy of Allogeneic Osteoblastic Cells (ALLOB®) Implantation in Rescue Interbody Fusion | |||||||||||||
Medical condition: Failed lumbar fusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000889-35 | Sponsor Protocol Number: CHUB-PIB | Start Date*: 2016-05-26 |
Sponsor Name:Centre Hospitalier Universitaire Brugmann | ||
Full Title: Comparison of two methods of administration of the epidural, by programmed intermittent bolus or continuous perfusion, on the incidence of instrumented deliveries and cesareans in primiparous women. | ||
Medical condition: Fist child delivery with epidural | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005247-14 | Sponsor Protocol Number: CHUB-Equidol | Start Date*: 2016-08-09 |
Sponsor Name:Centre Hospitalier Universitaire Brugmann | ||
Full Title: Effect of levobupivacaine infiltration versus placebo on perineal postpartum pain in episiotomy of primiparous, after instrumental delivery: randomized double blind clinical trial. | ||
Medical condition: Episiotomy (inclusion of primiparous patients giving birth by instrumental delivery -Suzor forceps, vacuum extraction, Thierry spatulas with episiotomy). | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004480-31 | Sponsor Protocol Number: ALLOB-IF1 | Start Date*: 2014-05-27 | |||||||||||
Sponsor Name:Bone Therapeutics S.A. | |||||||||||||
Full Title: A Pilot Phase IIa, Multicentre, Open, Proof-of-concept Study on the Safety and the Efficacy of Allogeneic Osteoblastic Cells (ALLOB®) implantation in Lumbar Spinal Fusion | |||||||||||||
Medical condition: Degenerative disc disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001160-38 | Sponsor Protocol Number: lidocaineplif | Start Date*: 2014-01-08 | |||||||||||||||||||||
Sponsor Name:ZNA Middelheim | |||||||||||||||||||||||
Full Title: Impact of intravenous lidocaine infusion on postoperative analgesia for one or two level posterior lumbar interbody fusion surgery | |||||||||||||||||||||||
Medical condition: The postoperative pain intensity after posterior interbody fusion surgery is often intense and difficult to treat with IV morphine and paracetamol alone. Besides, the use of opioids is often associ... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004573-29 | Sponsor Protocol Number: DORI-06 | Start Date*: 2005-01-21 | |||||||||||
Sponsor Name:Peninsula Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Multicenter, Phase 3 Study to Confirm the Safety and Efficacy of Intravenous Doripenem in Complicated Lower Urinary Tract Infection or Pyelonephritis | |||||||||||||
Medical condition: Complicated Lower Urinary Tract Infection or Pyelonephritis MedDRA: Lower urinary tract infection or pyelonephritis (10024981 and/or 10059517) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000675-34 | Sponsor Protocol Number: EU 101 | Start Date*: 2004-12-21 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: A Prospective, Randomized, Controlled, Multi-center, (Pilot) Study of Osigraft® in Instrumented Posterolateral Fusions | ||
Medical condition: Subjects qualifying for decompression and fusion of one spinal level (L3-S1) with the use of autograft will be recruited through the medical institutions of participating investigators. All subject... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000904-36 | Sponsor Protocol Number: IBS-DOTIG-ECM-2202 | Start Date*: 2022-05-09 | |||||||||||
Sponsor Name:Instituto de Investigación Biomédica de Salamanca | |||||||||||||
Full Title: Randomized clinical trial to evaluate the dose and administration time of indocyanine green in near-infrared fluorescent cholangiography during laparoscopic cholecystectomy. | |||||||||||||
Medical condition: Laparoscopic cholecystectomy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000981-70 | Sponsor Protocol Number: 1408143 | Start Date*: 2016-03-08 |
Sponsor Name:Centre Hospitalier Universitaire de Saint-Etienne | ||
Full Title: A multicentre, randomised, double-blind, controlled, phase IIIb study to assess the efficacy and safety of Rivaroxaban 10mg od versus Enoxaparin 4000 IU for VTE PROphylaxis in NOn Major Orthopaedic... | ||
Medical condition: Venous Thromboembolism Prophylaxis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) ES (Completed) CZ (Completed) NL (Completed) DE (Completed) GR (Completed) PL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004255-70 | Sponsor Protocol Number: 205687 | Start Date*: 2017-05-29 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: A randomised, double-blind, parallel group PhIII study to assess the clinical efficacy and safety of 100 mg SC Mepolizumab as an add on to maintenance treatment in adults with severe bilateral nasa... | |||||||||||||
Medical condition: Treatment of nasal polyposis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) SE (Completed) NL (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003372-73 | Sponsor Protocol Number: ZTI-01-200 | Start Date*: 2016-04-11 | ||||||||||||||||
Sponsor Name:Zavante Therapeutics, Inc. | ||||||||||||||||||
Full Title: A Multi-center, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of ZTI-01 Versus Piperacillin/Tazobactam in the Treatment of Complicated Urinary Tract Infections, In... | ||||||||||||||||||
Medical condition: Complicated Urinary Tract Infections, Including Acute Pyelonephritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) HU (Completed) LT (Completed) LV (Completed) SK (Completed) PL (Completed) EE (Completed) GR (Completed) BG (Completed) RO (Completed) HR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000407-41 | Sponsor Protocol Number: FSJD-ESCOKETA-2010 | Start Date*: 2011-07-01 | |||||||||||
Sponsor Name:FUNDACIÓ SANT JOAN DE DEU | |||||||||||||
Full Title: ASSESSMENT OF THE ANALGESIC EFFICACY AND TOLERABILITY OF THE PERIOPERATIVE ASSOCIATION OF KETAMINE WITH OPIATES AFTER POSTERIOR VERTEBRAL FUSION SURGERY IN CHILDREN WITH IDIOPATHIC SCOLIOSIS | |||||||||||||
Medical condition: POSTERIOR VERTEBRAL FUSION SURGERY IN CHILDREN WITH IDIOPATHIC SCOLIOSIS | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000545-78 | Sponsor Protocol Number: Rempex-505 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Rempex Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF CARBAVANCE™ (MEROPENEM/RPX7009) COMPARED TO PIPERACILLIN/TAZOBACTAM IN TH... | ||||||||||||||||||
Medical condition: complicated urinary tract infection (cUTI) or acute pyelonephritis (AP) with or without concurrent bacteremia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) CZ (Completed) SK (Completed) IT (Completed) ES (Completed) PL (Completed) SI (Completed) BG (Completed) GR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-003671-35 | Sponsor Protocol Number: SPR994-301 | Start Date*: 2019-04-18 | |||||||||||
Sponsor Name:Spero Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Double-dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) ... | |||||||||||||
Medical condition: complicated urinary tract infection or acute pyelonephritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) LV (Completed) BG (Completed) HU (Completed) PL (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004868-35 | Sponsor Protocol Number: AT-301 | Start Date*: 2018-08-23 | ||||||||||||||||
Sponsor Name:Allecra Therapeutics SAS | ||||||||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Cefepime- AAI101 Compared to Piperacillin/Tazobactam in the Treatment of Complicated Ur... | ||||||||||||||||||
Medical condition: Complicated urinary tract infections including acute pyelonephritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: LT (Completed) LV (Completed) ES (Completed) BG (Completed) SK (Completed) PL (Completed) HU (Completed) HR (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
